IAM insider trading
Iambic Therapeutics, Inc.
In the past 41 days, 1 insider bought $11.5M of Iambic Therapeutics, Inc. stock in 1 open-market purchase. The largest purchase was $11.5M by Evan Lockwood Rachlin (Director) on Oct 16, 2026.
Insider purchases
| Insider | Value | Holdings | Signal | Traded / filed |
|---|---|---|---|---|
Evan Lockwood Rachlin Director |
$11.5M 718,750 sh @ $16.00 |
+38.4% | High
|
Oct 16, 2026 Filed Oct 19, 2026 |
Insider sales
No open-market sales by insiders in this period.
The week's top insider buys, every Monday
Clusters, CEO purchases and the largest buys from the past week's SEC filings. One free email a week.
Unsubscribe any time. No spam, no stock picks.